Document is current
Any future updates will be listed below
-
Authors
Patel, Piyush
Jin, Chunsheng
Nookaew, Intawat
Robeson, Michael
Malipatlolla, Dilip K.
Devarakonda, Sravani
Rascón, Ana
Nyman, Margareta
Karlsson, Niclas G.
Wold, Agnes E.
Sjöberg, Fei
Bull, Cecilia
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences of the National Institutes of Health (P20GM125503)
Stiftelsen Jubileumsklinikens Forskningsfond mot Cancer (2018-194)
The Swedish Cancer Society (2018-656)
The Swedish State under the agreement between the Swedish Government and the county councils, the ALF-agreement (ALFGBG-727821)
Sahlgrenska Academy’s project-specific grant for PhD students
- License Information
-
More Information
Article History
Received: 13 December 2024
Accepted: 17 June 2025
First Online: 4 July 2025
Competing interests
: A.R. is a part-time employee of Glucanova, the provider of the bioprocessed oat bran. She is also the author of the patent for its preparation. All other authors declare no financial or non-financial competing interests.
